Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Change in Accured Expenses (2016 - 2025)

Bruker's Change in Accured Expenses history spans 15 years, with the latest figure at $66.2 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 696.4% year-over-year to $66.2 million; the TTM value through Dec 2025 reached $85.3 million, up 453.9%, while the annual FY2025 figure was -$26.7 million, 273.38% down from the prior year.
  • Change in Accured Expenses reached $66.2 million in Q4 2025 per BRKRP's latest filing, up from -$11.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $66.2 million in Q4 2025 to a low of -$22.5 million in Q2 2021.
  • Average Change in Accured Expenses over 5 years is $10.5 million, with a median of $12.9 million recorded in 2022.
  • Peak YoY movement for Change in Accured Expenses: surged 13200.0% in 2023, then tumbled 202.78% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $15.5 million in 2021, then decreased by 16.77% to $12.9 million in 2022, then fell by 16.28% to $10.8 million in 2023, then crashed by 202.78% to -$11.1 million in 2024, then skyrocketed by 696.4% to $66.2 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Change in Accured Expenses are $66.2 million (Q4 2025), -$11.1 million (Q4 2024), and $20.9 million (Q3 2024).